XDx Raises $14.4 Million, After Pulling IPO

XDx Inc., a Brisbane, Calif.-based developer of noninvasive gene expression tests for the monitoring of immune-mediated, has raised $14.4 million in Series G funding. Bristol Myers Squibb led the round, and was joined by return backers Burrill Venture Capital, DAG Ventures, Integral Capital Partners, Intel Capital, Kleiner Perkins Caulfield & Byers, New Leaf Venture Partners and TPG Biotechnology. The company previously raised around $86 million, and last fall canceled a proposed IPO.

North AmericaUSBriefs